Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by DJDawg

V.TLT

RE:New FDA-approved drug NSLC

3-5% of nsclc is alk+ so helpful for some but not many. 

3 days ago

V.TLT

RE:RE:RE:RE:Of science interest

Does anyone know of any TLD-1433 on ROS generation when light activated. I...

3 days ago

V.TLT

RE:RE:Of science interest

That meant to be a dash. No intervention = a certain amount of reactive...

3 days ago

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:JV with Merck's Keyteuda a bad idea...

Sadly I agree. I think RDW is holding this one tight to his chest and that...

3 days ago

V.TLT

Of science interest

I was reading through some of the science NRs they put out a while back...

3 days ago

V.TLT

talk about low volume

Someone just tried to buy 1000 shares (194 USD worth) on US side (TLTFF) and...

4 days ago

V.TLT

Crazy world of health care valuations

Saw an article on my feed re Keros (KROS). Working on pulm art hypertension...

10 days ago

V.TLT

RE:RE:RE:SURVEY

I just want to thank everyone who added in to the survey. It is so cool to...

10 days ago

V.TLT

RE:SURVEY

3.5 years Edmonton, Alberta

11 days ago

V.TLT

stock volume

On the main exchange, no shares bought or sold. Clearly no one in a rush to...

11 days ago

V.TLT

RE:Base shelf prospectus ! How is this diff than PP ?

The only thing I like about base shelf is no warrants to dilute as well. I...

December 9, 2024

V.TLT

RE:RE:RE:Not sure if TLT can attack this gene

I once looked up an article about how different transferrin expression is...

December 7, 2024

V.TLT

RE:Not sure if TLT can attack this gene

That is the great thing about Rutherrin. It is tumour agnostic and mutation...

December 6, 2024

V.TLT

Stock drop today

For those of you wondering about the price drop today, it is an atypical...

December 6, 2024

V.TLT

RE:RE:long haul vs short term

Agreed. Medical advances come in waves. Immunotherapy and checkpoint...

December 6, 2024

V.TLT

long haul vs short term

If TLT were only a bladder cancer company I would be nervous, mainly because...

December 6, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:We have serious competition!

If a company changes exchange your broker just journals them over. Nothing...

December 5, 2024

V.TLT

RE: Q3 2024 Earnings Call Transcript

Reading the transcript it was interesting to read about the preparation for...

December 5, 2024

V.TLT

RE:RE:We have serious competition!

All these biologic agents have good initial results but drop off quite...

December 5, 2024

V.TLT

RE:We have serious competition!

Good numbers but small patient numbers so far. The protocol is like all the...

December 5, 2024

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Visionstate Corp.

Visionstate Corp. V.VIS

Visionstate Corp.is a growth-oriented company that invests in the research and development of the Internet of Things, big ... view more »